| 1) |
乾 純和,他 |
| 住民検診において Helicobacter pylori 検査はどのように活用されるか? - HP・PG 同時測定による胃癌検診(ABCD 検診)の試み - 日本ヘリコバクター学会誌.2007, 9:(2) 印刷中 |
| 2) |
鵜浦雅志 |
| 石川県羽咋市におけるペプシノゲン・胃X線2段階法における3年間の胃がん検診成績 - 過去5年間の胃X線検診との比較 - 日本がん検診・診断学会誌.2007, 15:(2) 印刷中 |
| 3) |
藤城光弘,三木一正,他 |
| 職域における血清マーカーによる胃がん検診の現状を今後の展望 日本がん検診・診断学会誌.2007, 15:(2) 印刷中 |
| 4) |
三木一正 |
| 胃がんハイリスクストラテジーにもとづく胃内視鏡検診 日本消化器内視鏡学会雑誌.2007, 49:(9), 2451-2461 |
| 5) |
伊藤史子,渡邊能行,三木一正 |
| 地域住民を対象とした2段階ペプシノゲン法胃がん検診の死亡減少効果の検討 日本がん検診・診断学会誌.2007, 14:(2), 156-160 |
| 6) |
鵜浦雅志,米島博嗣,池田直樹 |
| 石川県羽咋市のペプシノゲン検査を併用した胃がん検診成績 日消がん検診誌.2006, 44:459-463 |
| 7) |
三木一正 |
| 胃がんスクリーニングの最前線 医療.2006, 60:287-292 |
| 8) |
三木一正 |
| 胃がんスクリーニングのハイリスクストラテジーに関する研究 日消集検誌.2006, 44:127-139 |
| 9) |
柳岡公彦 他,他 |
| 前癌状態としての慢性胃炎の評価と胃癌検診 消化器内視鏡.2006, 463-468 |
| 10) |
井上和彦,他 |
| 血清ペプシノゲン法とヘリコバクターピロリ抗体価を用いた胃の“健康度”評価 - 同日に行った内視鏡検査を基準として - 日消集検誌.2005, 43:332-339 |
| 1) |
Miki K, Urita Y |
| Using serum pepsinogens wisely in a clinical practice Journal of Digestive Diseases 2007; 8; 8-14 |
| 2) |
Yoshihara M, Watanabe Y, et al. |
| Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: A case-control study Scandinavian Journal of Gastroenterology 2007; 42: 760-764 |
| 3) |
Miki K |
| Gastric cancer screening using the serum pepsinogen test method Gastric Cancer (2006) 9: 245-253 |
| 4) |
Sasazuki S, Inoue M, Iwasaki M, et al. |
| Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study Cancer Epidemiol Biomarkers Prev 2006; 15(7). July 2006 |
| 5) |
Oishi Y, Kiyohara Y, Kubo M, et al. |
| The Serum Pepsinogen Test as a Predictor of Gastric Cancer: The Hisayama Study American Journal of Epidemiology 2006; 163: 629-637 |
| 6) |
Nomura A.M.Y, Miki K, et al. |
| Helicobacter pylori, Pepsinogen, and Gastric Adenocarcinoma in Hawaii The Journal of Infectious Diseases 2005; 191: 2075-2081 |
| 7) |
Ohata H, Ichinose M, Miki K, et al. |
| Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography Cancer Sci 2005, 96:713-720 |
| 8) |
Ohata H, Ichinose M, et al. |
| Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer International Journal of Cancer 2004, 109: 138-143 |
| 9) |
Dinis-Rebeiro M, Yamaki G, Miki K, et al. |
| Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening Journal of Medical screening 2004; 11: 141-147 |
| 10) |
Miki K, et al. |
| Usefulness of Gastric Cancer Screening Using the Serum Pepsinogen Test Method The American Journal of Gastroenterology 2003, 98:735-739 |
| 11) |
Miki K, Urita Y, Ishikawa F, et al. |
| Effect of Bifidobacterium bifidum Fermented Milk on Helicobacter pylori and Serum Pepsinogen Levels in Humans Journal of Daily Science 2007, 90: 2630-2640 |
| 12) |
Kawai T, Miki K, et al. |
| Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan Inflammopharmacology 2007; 15: 31-35 |
| 13) |
Fujishiro M, Oka M, Yahagi N, Miki K, et al. |
| Correlation of Serum Pepsinogens and Gross Appearances Combined with Histology in Early Gastric Cancer J.Exp.Clin. Cancer Res. 2006, 25: 207-212 |
| 14) |
Fujishiro M, Yahagi N, Miki K, et al. |
| Early Detection of Asymptomatic Gastric Cancers Using Serum Pepsinogen Levels to Indicate Endoscopic Submucosal Dissection for Better Quality of Life MEDIMOND S.r.l. 2005, F504C0102: 145-150 |
| 15) |
Watabe H, Mitsushima T, Yamaji M, et al. |
| Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study Gut 2005; 54: 764-768 |
| 16) |
Muto M, Saito Y, Miki K, et al. |
| A case of gastric cancer with high pepsinogen II levels in both serum and ascites Digestive Endoscopy (2000)12, 42-45 |